Conduction disorders following transcatheter aortic valve replacement using acurate Neo2 transcatheter heart valve: A propensity matched analysis.

[1]  S. Toggweiler,et al.  ACURATE neo2 Transcatheter aortic valve implantation without balloon aortic valvuloplasty - direct ACURATE neo2. , 2024, International journal of cardiology.

[2]  M. Joner,et al.  Multicenter comparison of transcatheter aortic valve implantation with the self-expanding ACURATE neo2 versus Evolut PRO transcatheter heart valves , 2023, Clinical research in cardiology : official journal of the German Cardiac Society.

[3]  P. Teirstein,et al.  Three-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis. , 2023, Journal of the American College of Cardiology.

[4]  C. Terkelsen,et al.  Clinical outcomes of the ACURATE neo2 transcatheter heart valve: a prospective, multicenter, observational, post-market surveillance study. , 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[5]  P. Pibarot,et al.  Impact of Paravalvular Leak on Outcomes After Transcatheter Aortic Valve Implantation: Meta-Analysis of Kaplan-Meier-derived Individual Patient Data , 2022, Structural heart : the journal of the Heart Team.

[6]  M. Joner,et al.  ACURATE neo2 versus SAPIEN 3 Ultra for transcatheter aortic valve implantation. , 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[7]  R. Kornowski,et al.  Comparison of transcatheter aortic valve replacement with the ACURATE neo2 versus Evolut PRO/PRO+ devices. , 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[8]  D. Wood,et al.  Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2. , 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[9]  C. Cuccia,et al.  Transcatheter Aortic Valve Replacement With Self-Expanding ACURATE neo2: Postprocedural Hemodynamic and Short-Term Clinical Outcomes. , 2022, JACC. Cardiovascular interventions.

[10]  V. Guetta,et al.  Generational Differences in Outcomes of Self-Expanding Valves for Transcatheter Aortic Valve Replacement. , 2022, The Journal of invasive cardiology.

[11]  H. Baumgartner,et al.  Pacemaker implantation rate after TAVI with the latest generation balloon-expandable valve SAPIEN 3 Ultra , 2021, European Heart Journal.

[12]  P. Serruys,et al.  Paravalvular Aortic Regurgitation Severity Assessed by Quantitative Aortography: ACURATE neo2 versus ACURATE neo Transcatheter Aortic Valve Implantation , 2021, Journal of clinical medicine.

[13]  M. Joner,et al.  The ACURATE neo2 valve system for transcatheter aortic valve implantation: 30-day and 1-year outcomes , 2021, Clinical Research in Cardiology.

[14]  D. Wood,et al.  Long-Term Durability of the Next-Generation Acurate neo 2 Transcatheter Heart Valve: Insights From Bench Testing to 25 Years. , 2021, JACC. Cardiovascular interventions.

[15]  M. Niemelä,et al.  Impact of paravalvular regurgitation on the mid-term outcome after transcatheter and surgical aortic valve replacement. , 2020, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[16]  C. Hengstenberg,et al.  Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis , 2020, Circulation.

[17]  B. Ghanim,et al.  Evolution of outcome and complications in TAVR: a meta-analysis of observational and randomized studies , 2020, Scientific Reports.

[18]  P. Stella,et al.  Comparison of the Sapien 3 versus the ACURATE neo valve system: A propensity score analysis , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[19]  M. Dalby,et al.  Comparison of the self-expanding Evolut-PRO transcatheter aortic valve to its predecessor Evolut-R in the real world multicenter ATLAS registry. , 2020, International journal of cardiology.

[20]  D. Wood,et al.  Impact of Predilatation Prior to Transcatheter Aortic Valve Implantation With the Self-Expanding Acurate neo Device (from the Multicenter NEOPRO Registry). , 2020, American Journal of Cardiology.

[21]  T. Nazif,et al.  Three Generations of Self-Expanding Transcatheter Aortic Valves: A Report From the STS/ACC TVT Registry. , 2020, JACC. Cardiovascular interventions.

[22]  P. Leprince,et al.  Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement , 2019, Circulation.

[23]  B. Prendergast,et al.  Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial , 2019, The Lancet.

[24]  J. Leipsic,et al.  Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[25]  Andrew S. Mugglin,et al.  Transcatheter Aortic‐Valve Replacement with a Self‐Expanding Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[26]  I. Barbash,et al.  Efficacy and safety of new-generation transcatheter aortic valves: insights from the Israeli transcatheter aortic valve replacement registry , 2018, Clinical Research in Cardiology.

[27]  R. Kobza,et al.  Pacemaker implantation after transcatheter aortic valve: why is this still happening? , 2018, Journal of thoracic disease.

[28]  R. Kobza,et al.  Very low pacemaker rate following ACURATE neo transcatheter heart valve implantation. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[29]  D. Berman,et al.  A Highly Predictive Risk Model for Pacemaker Implantation After TAVR. , 2017, JACC. Cardiovascular imaging.

[30]  J. Chambers,et al.  Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. , 2017, European heart journal cardiovascular Imaging.

[31]  Y. Arbel,et al.  Comparison of the Edwards SAPIEN S3 Versus Medtronic Evolut-R Devices for Transcatheter Aortic Valve Implantation. , 2017, The American journal of cardiology.

[32]  E. Tuzcu,et al.  Clinical ResearchInterventional CardiologyIncidence, Predictors, and Outcomes of Aortic Regurgitation After Transcatheter Aortic Valve Replacement: Meta-Analysis and Systematic Review of Literature , 2013 .

[33]  S. Windecker,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.

[34]  Scott Lim,et al.  Two-year outcomes after transcatheter or surgical aortic-valve replacement. , 2012, The New England journal of medicine.

[35]  R. D'Agostino.  Propensity Scores in Cardiovascular Research , 2007, Circulation.